Author

Samira Dashti

Mashhad University of Medical Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Elyas MohammadiiD· 2 shared Mohammad Hadi SekhavatiiD· 2 shared Adil MardinoğluiD· 1 shared Cheng ZhangiD· 1 shared Han JiniD· 1 shared Mojtaba TahmoorespuriD· 1 shared Naghmeh SaediiD· 1 shared Neda Shafizade· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Elyas MohammadiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Drug repositioning for immunotherapy in breast cancer using single-cell and spatial transcriptomics analysis

Elyas Mohammadi, Han Jin, Cheng Zhang, Neda Shafizade, Samira Dashti, Simon Lam, Mojtaba Tahmoorespur, Adil Mardinoğlu, Mohammad Hadi Sekhavati

This study identifies immunomodulatory peptides deregulated in breast cancer using single-cell and spatial transcriptomics, and proposes drugs to modulate their expression.

medRxiv · Nov 18, 2022 · PreprintGenetic & Genomic Medicine

Design and Computational Analysis of a Chimeric Avian Influenza Antigen: A Yeast-displayed, Universal and Cross-protective Vaccine Candidate

Elyas Mohammadi, Zana Pirkhezranian, Samira Dashti, Naghmeh Saedi, Mohammad Hadi Sekhavati

The paper designs and computationally analyzes two chimeric avian influenza antigens, finding that the second design better interacts with a monoclonal antibody and could serve as a vaccine candidate.

bioRxiv · Sep 5, 2021 · PreprintBioinformatics